News
Abstract: Columnist and Deputy Opinion Editor Arshiya Pant argues that progress demands we challenge our definitive ...
The researchers engineered a compound that kills leukemia cells with potency comparable to FDA-approved therapies by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback